[Federal Register: March 11, 2009 (Volume 74, Number 46)]
[Notices]               
[Page 10593-10594]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr11mr09-84]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Data Coordinating Center for Autism and Other 
Development Disabilities Research, Program Announcement Number (PA) 
DD09-002; Epidemiologic and Surveillance and Epidemiologic Research of 
Duchenne and Becker Muscular Dystrophy, PA DD06-002

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 1 p.m.-4 p.m., March 26, 2009 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of the application received in response 
to ``Data Coordinating Center for Autism and Other Development 
Disabilities

[[Page 10594]]

Research, PA DD09-002; and the supplements received for 
Epidemiologic and Surveillance and Epidemiologic Research of 
Duchenne and Becker Muscular Dystrophy, PA DD06-002.''
    For Further Information Contact: Geneva L. Cashaw, Designated 
Federal Official, CDC, 4770 Buford Highway, NE., Mailstop K-92, 
Telephone (770) 488-8390.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: March 4, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-5117 Filed 3-10-09; 8:45 am]

BILLING CODE 4163-18-P